Medirom Healthcare (MRM) | Financial Analysis & Statements
Medirom Healthcare Technologies Inc. Micro-cap Consumer Cyclical
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
8.1B
Total Liabilities
6.9B
Shareholders Equity
1.2B
Debt to Equity
5.81
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Medirom Healthcare Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 8.3B | 6.8B | 7.0B | 5.4B | 3.3B |
| Cost of Goods Sold | 6.1B | 5.3B | 5.1B | 4.0B | 2.9B |
| Gross Profit | 2.2B | 1.6B | 1.9B | 1.4B | 429.0M |
| Gross Margin % | 27.1% | 23.0% | 27.4% | 26.2% | 12.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 2.2B | 2.0B | 1.8B | 1.8B | 1.1B |
| Other Operating Expenses | -13.9M | -21.4M | -20.6M | -27.8M | -111.6M |
| Total Operating Expenses | 2.2B | 1.9B | 1.8B | 1.8B | 957.0M |
| Operating Income | 18.6M | -370.2M | 117.6M | -379.5M | -528.0M |
| Operating Margin % | 0.2% | -5.4% | 1.7% | -7.0% | -15.8% |
| Non-Operating Items | |||||
| Interest Income | 8.0K | 1.1M | 6.1M | 839.0K | 1.3M |
| Interest Expense | 49.7M | 36.9M | 9.8M | 12.0M | 13.2M |
| Other Non-Operating Income | 78.8M | 426.6M | 65.9M | -23.8M | -86.8M |
| Pre-tax Income | 47.7M | 20.6M | 179.8M | -414.5M | -626.7M |
| Income Tax | -90.5M | -94.4M | 30.8M | 576.2M | -87.5M |
| Effective Tax Rate % | -189.6% | -457.9% | 17.1% | 0.0% | 0.0% |
| Net Income | 138.2M | 115.0M | 149.0M | -990.7M | -539.2M |
| Net Margin % | 1.7% | 1.7% | 2.1% | -18.3% | -16.1% |
| Key Metrics | |||||
| EBITDA | 351.6M | -130.4M | 358.8M | -228.1M | -444.7M |
| EPS (Basic) | - | $23.64 | $30.54 | $-203.13 | $-223.88 |
| EPS (Diluted) | - | $22.34 | $27.23 | $-203.13 | $-223.88 |
| Basic Shares Outstanding | - | 4882501 | 4877405 | 4877405 | 698867055 |
| Diluted Shares Outstanding | - | 4882501 | 4877405 | 4877405 | 698867055 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Medirom Healthcare Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 329.4M | 106.3M | 605.5M | 370.6M | 1.4B |
| Short-term Investments | 6.2M | 26.5M | 26.5M | 26.5M | 32.5M |
| Accounts Receivable | 1.4B | 621.9M | 534.7M | 312.3M | 148.5M |
| Inventory | 151.6M | 140.0M | 114.1M | 18.7M | 8.0M |
| Other Current Assets | 217.2M | 257.9M | 292.6M | 111.2M | - |
| Total Current Assets | 2.7B | 1.8B | 2.4B | 1.4B | 2.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.1B | 2.1B | 2.0B | 1.8B | 1.6B |
| Goodwill | 1.9B | 1.9B | 1.5B | 1.6B | 399.1M |
| Intangible Assets | 1.1B | 920.7M | 403.7M | 391.0M | 97.6M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 450.8M | 214.1M | 113.0M | 209.1M | 852.0M |
| Total Non-Current Assets | 5.4B | 5.1B | 4.4B | 4.4B | 3.6B |
| Total Assets | 8.1B | 6.8B | 6.7B | 5.8B | 5.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.0B | 137.7M | 207.6M | 230.9M | 67.0M |
| Short-term Debt | 1.9B | 1.3B | 868.9M | 917.5M | 900.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 414.7M | 370.2M | 525.6M | 418.8M | 118.9M |
| Total Current Liabilities | 4.2B | 3.6B | 3.6B | 3.2B | 2.7B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.1B | 2.4B | 2.4B | 1.9B | 1.7B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 253.6M | 271.7M | 335.0M | 354.1M | 383.2M |
| Total Non-Current Liabilities | 2.7B | 3.1B | 3.2B | 2.8B | 2.6B |
| Total Liabilities | 6.9B | 6.6B | 6.8B | 6.0B | 5.2B |
| Equity | |||||
| Common Stock | 352.6M | 20.0M | 1.2B | 1.2B | 1.2B |
| Retained Earnings | 229.0M | 80.3M | -2.5B | -2.7B | -1.7B |
| Treasury Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.2B | 216.0M | -59.4M | -208.3M | 491.3M |
| Key Metrics | |||||
| Total Debt | 4.0B | 3.6B | 3.2B | 2.8B | 2.6B |
| Working Capital | -1.5B | -1.8B | -1.3B | -1.8B | -565.4M |
Balance Sheet Composition
Medirom Healthcare Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 138.2M | 115.0M | 149.0M | -990.7M | -539.2M |
| Depreciation & Amortization | 290.0M | 252.6M | 184.1M | 126.2M | 62.3M |
| Stock-Based Compensation | - | 0 | 0 | 196.9M | 0 |
| Working Capital Changes | 988.1M | 263.4M | -440.5M | -45.9M | -107.1M |
| Operating Cash Flow | 1.3B | 575.1M | -107.5M | -161.3M | -689.4M |
| Investing Activities | |||||
| Capital Expenditures | -71.4M | -135.8M | -80.1M | -95.7M | -70.3M |
| Acquisitions | 887.1M | 584.8M | 703.7M | 54.2M | -99.2M |
| Investment Purchases | -5.7M | -3.1M | 0 | -78.9M | -26.7M |
| Investment Sales | 29.6M | 0 | 0 | 6.0M | 63.0M |
| Investing Cash Flow | 854.8M | 457.6M | 626.2M | -65.8M | -109.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 300.0M | 0 | 547.6M | 0 | 775.0M |
| Debt Repayment | -685.0M | -99.1M | -207.5M | -251.1M | -386.4M |
| Financing Cash Flow | 605.0M | 461.2M | 177.8M | -515.6M | 1.2B |
| Free Cash Flow | -1.9B | -1.6B | -852.2M | -671.0M | -470.5M |
| Net Change in Cash | 2.7B | 1.5B | 696.5M | -742.7M | 447.0M |
Cash Flow Trend
Medirom Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
3.09
Price to Book
5.92
Price to Sales
0.00
Profitability Ratios
Profit Margin
0.50%
Operating Margin
-25.84%
Return on Equity
53.19%
Return on Assets
-1.78%
Financial Health
Current Ratio
0.24
Debt to Equity
786.42
Beta
1.07
Per Share Data
EPS (TTM)
$0.37
Book Value per Share
$0.19
Revenue per Share
$1,221.72
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MRM | 9.2M | 3.09 | 5.92 | 53.19% | 0.50% | 786.42 |
| Rollins | 27.5B | 50.19 | 19.16 | 38.94% | 14.00% | 75.53 |
| Service | 11.8B | 22.79 | 7.57 | 34.52% | 12.60% | 322.88 |
| Medifast | 121.1M | 531.50 | 0.57 | -9.13% | -4.84% | 5.38 |
| WW International | 92.7M | 1.23 | 0.29 | 332.00% | 148.60% | 147.33 |
| Regis | 67.7M | 0.61 | 0.37 | 94.31% | 50.79% | 182.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.






